Table 1: Baseline characteristics of preterm neonates exposed to brimonidiine tartrate 0.2% and timolol maleate 0.5% ophthalmic drops
Table 1: Baseline characteristics of preterm neonates exposed to brimonidiine tartrate 0.2% and timolol maleate 0.5% ophthalmic drops